Ted Keysor

Ted Keysor has an extensive work experience spanning over several companies and roles. Ted currently serves as the Chief Operating Officer at Kisbee Therapeutics, where they focus on developing therapeutic agents for neurodegenerative diseases. Prior to this, Ted worked at Cerevel Therapeutics, LLC as the Vice President of Program and Portfolio Management from 2019 to 2021. Before that, they held various Vice President positions at Biogen, including roles in R&D Quality, Operations, and Performance, R&D Business Operations, and Programme Leadership & Business Operations. Ted also worked at Pfizer Inc. as the Director of Business Innovation & Strategy, and at Deloitte Consulting as a Senior Manager. Ted started their career as a Research Scientist/Product Development Manager at Exact Sciences and held similar positions at Pavonis Inc. and CuraGen Corporation.

Ted Keysor completed their Bachelor of Arts degree in Biology from Colby College from 1993 to 1997. Later, from 2002 to 2004, they pursued their Master of Business Administration (MBA) with a specialization in Managing Technology-Intensive Enterprises (MTIE) from Babson F.W. Olin Graduate School of Business.